Beijing Tiantan Biological Products Corp Ltd (600161) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.021x

Based on the latest financial reports, Beijing Tiantan Biological Products Corp Ltd (600161) has a cash flow conversion efficiency ratio of 0.021x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥318.80 Million ≈ $46.65 Million USD) by net assets (CN¥14.95 Billion ≈ $2.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600161 equity financing ratio to measure how much of total assets are equity-financed.

Beijing Tiantan Biological Products Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how Beijing Tiantan Biological Products Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 600161 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

Beijing Tiantan Biological Products Corp Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Beijing Tiantan Biological Products Corp Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fluidra MC:FDR	0.086x
Wix.Com Ltd NASDAQ:WIX	-0.476x
Ventia Services Group Ltd AU:VNT	0.348x
Juneyao Airlines SHG:603885	0.225x
Kiniksa Pharmaceuticals Ltd NASDAQ:KNSA	0.083x
Chipbond Technology TWO:6147	0.042x
SpringWorks Therapeutics Inc NASDAQ:SWTX	-0.165x
EQB Inc. TO:EQB	-0.163x

Annual Cash Flow Conversion Efficiency for Beijing Tiantan Biological Products Corp Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of Beijing Tiantan Biological Products Corp Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Beijing Tiantan Biological Products Corp.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥14.53 Billion ≈ $2.13 Billion	CN¥819.78 Million ≈ $119.96 Million	0.056x	-69.94%
2023-12-31	CN¥12.75 Billion ≈ $1.87 Billion	CN¥2.39 Billion ≈ $350.26 Million	0.188x	+89.27%
2022-12-31	CN¥11.36 Billion ≈ $1.66 Billion	CN¥1.13 Billion ≈ $164.77 Million	0.099x	+3.84%
2021-12-31	CN¥10.27 Billion ≈ $1.50 Billion	CN¥980.35 Million ≈ $143.46 Million	0.095x	-17.98%
2020-12-31	CN¥6.03 Billion ≈ $882.52 Million	CN¥702.11 Million ≈ $102.74 Million	0.116x	-6.18%
2019-12-31	CN¥5.18 Billion ≈ $757.61 Million	CN¥642.47 Million ≈ $94.01 Million	0.124x	-20.43%
2018-12-31	CN¥4.35 Billion ≈ $636.07 Million	CN¥677.92 Million ≈ $99.20 Million	0.156x	+127.40%
2017-12-31	CN¥3.18 Billion ≈ $465.96 Million	CN¥218.39 Million ≈ $31.96 Million	0.069x	-60.92%
2016-12-31	CN¥2.44 Billion ≈ $357.19 Million	CN¥428.37 Million ≈ $62.68 Million	0.175x	-17.08%
2015-12-31	CN¥2.24 Billion ≈ $327.23 Million	CN¥473.26 Million ≈ $69.25 Million	0.212x	-1.81%
2014-12-31	CN¥2.22 Billion ≈ $324.51 Million	CN¥477.95 Million ≈ $69.94 Million	0.216x	-17.19%
2013-12-31	CN¥2.18 Billion ≈ $318.46 Million	CN¥566.43 Million ≈ $82.89 Million	0.260x	+7.07%
2012-12-31	CN¥1.78 Billion ≈ $260.05 Million	CN¥432.00 Million ≈ $63.22 Million	0.243x	-0.46%
2011-12-31	CN¥1.45 Billion ≈ $211.62 Million	CN¥353.15 Million ≈ $51.68 Million	0.244x	+50.88%
2010-12-31	CN¥1.14 Billion ≈ $167.13 Million	CN¥184.85 Million ≈ $27.05 Million	0.162x	-65.73%
2009-12-31	CN¥949.13 Million ≈ $138.89 Million	CN¥448.23 Million ≈ $65.59 Million	0.472x	+29.34%
2008-12-31	CN¥756.97 Million ≈ $110.77 Million	CN¥276.39 Million ≈ $40.44 Million	0.365x	+72.54%
2007-12-31	CN¥725.57 Million ≈ $106.17 Million	CN¥153.55 Million ≈ $22.47 Million	0.212x	-2.89%
2006-12-31	CN¥708.35 Million ≈ $103.65 Million	CN¥154.36 Million ≈ $22.59 Million	0.218x	+10.72%
2005-12-31	CN¥669.09 Million ≈ $97.91 Million	CN¥131.69 Million ≈ $19.27 Million	0.197x	+13.83%
2004-12-31	CN¥636.79 Million ≈ $93.18 Million	CN¥110.11 Million ≈ $16.11 Million	0.173x	+64.78%
2003-12-31	CN¥599.70 Million ≈ $87.76 Million	CN¥62.93 Million ≈ $9.21 Million	0.105x	-64.06%
2002-12-31	CN¥289.04 Million ≈ $42.30 Million	CN¥84.38 Million ≈ $12.35 Million	0.292x	+81.90%
2001-12-31	CN¥289.68 Million ≈ $42.39 Million	CN¥46.49 Million ≈ $6.80 Million	0.160x	-6.46%
2000-12-31	CN¥279.21 Million ≈ $40.86 Million	CN¥47.90 Million ≈ $7.01 Million	0.172x	+12.68%
1999-12-31	CN¥279.67 Million ≈ $40.92 Million	CN¥42.58 Million ≈ $6.23 Million	0.152x	+70.68%
1998-12-31	CN¥265.80 Million ≈ $38.89 Million	CN¥23.71 Million ≈ $3.47 Million	0.089x	--

About Beijing Tiantan Biological Products Corp Ltd

SHG:600161 China Biotechnology

Market Cap

$3.54 Billion

CN¥24.22 Billion CNY

Market Cap Rank

#4430 Global

#697 in China

Share Price

CN¥12.25

Change (1 day)

-2.23%

52-Week Range

CN¥11.41 - CN¥20.63

All Time High

CN¥74.24